EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decreased expression of P-glycoprotein in the placenta of women with autoimmune disease

Angela Pollinzi, Kamelia Mirdamadi, Navaz Karimian Pour, Rashi Asthana-Nijjar, Dennis Lee, Ori Nevo, Micheline Piquette-Miller

Drug Metabolism and Disposition · 2025

DOI: 10.1016/j.dmd.2024.100031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Angela Pollinzi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Placenta, Lupus Erythematosus, Systemic, Autoimmune Diseases, ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune diseases (ADs), such as systemic lupus erythematosus (SLE), require multiple medications to ensure maternal-fetal health during pregnancy. These medications are often substrates for placental transporters that could cross over to the fetal compartment. However, the effects of ADs on placental transporters remain poorly understood. This study aimed to investigate the impact of ADs on placental transporters and key inflammatory cytokines. Human preterm and term placentas from AD-affected women (n = 28) and gestational age-matched controls (n = 38) were collected. The placentas were examined for transporter expression via quantitative real-time PCR and immunodetection. Subgroup analysis and untargeted proteomic analysis of samples from patients with SLE were performed. P-glycoprotein (P-gp/ABCB1) and organic anion transporter 4 (OAT4/SLC22A11) mRNA expression were significantly decreased and expression of T helper 17- associated cytokines were increased in preterm and term AD placenta relative to controls. P-gp protein expression was also downregulated in preterm, but not in term AD placenta. Subgroup analysis of SLE also detected downregulation of P-gp and OAT4 at the mRNA level in preterm samples. Proteomic analysis of SLE and control samples indicated global changes in proteins related to processes like inflammation, oxidative stress, angiogenesis, and hemostasis. These findings elucidate that ADs such as SLE are associated with the downregulation of the ABC transporter P-gp in the placenta as well as global changes to the placenta proteome. Dysregulation of cytokines and associated pathways was also observed and postulated to cause changes in placental transporters. Future studies that validate these mechanisms could offer potential strategies to mitigate inflammation-mediated alterations in placental transporters, ultimately improving fetal and neonatal health. SIGNIFICANCE STATEMENT: Autoimmune diseases have significant effects on the placenta, influencing pregnancy outcomes and the effectiveness of prescribed medications. The study revealed that autoimmune diseases induce inflammatory cytokines in the placenta and were associated with a significant downregulation of P-glycoprotein. Additionally, in patients affected by lupus, proteomics uncovered the enrichment of pathways associated with placental damage and dysfunction. This work will help inform care plans for these patients by identifying clinically relevant proteins that are affected by the disease, improving maternal-fetal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlacentaLupus Erythematosus, SystemicAutoimmune DiseasesATP Binding Cassette Transporter, Subfamily B, Member 1Pregnancy ComplicationsHumansFemalePregnancyAdultCytokinesProteomicsATP Binding Cassette Transporter, Subfamily BRNA, MessengerDown-RegulationCase-Control Studies

Stichwörter der Autor:innen

Autoimmune diseaseCytokinesDrug transportersLupusP-glycoproteinPlacenta

Substanzen

CytokinesATP Binding Cassette Transporter, Subfamily B, Member 1ATP Binding Cassette Transporter, Subfamily BRNA, MessengerABCB1 protein, human

Autor:innen und Institutionen

  • Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
  • Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.
  • Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada. Electronic address: m.piquette.miller@utoronto.ca.

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Pollinzi, A., Mirdamadi, K., Karimian Pour, N., Asthana-Nijjar, R., Lee, D., Nevo, O., & Piquette-Miller, M. (2025). Decreased expression of P-glycoprotein in the placenta of women with autoimmune disease. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2024.100031

Vancouver

Pollinzi A, Mirdamadi K, Karimian Pour N, Asthana-Nijjar R, Lee D, Nevo O, et al. Decreased expression of P-glycoprotein in the placenta of women with autoimmune disease. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2024.100031

BibTeX
@article{Pollinzi2025,
  author = {Pollinzi, Angela and Mirdamadi, Kamelia and Karimian Pour, Navaz and Asthana-Nijjar, Rashi and Lee, Dennis and Nevo, Ori and Piquette-Miller, Micheline},
  title = {Decreased expression of P-glycoprotein in the placenta of women with autoimmune disease},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  doi = {10.1016/j.dmd.2024.100031}
}
Kostenlos starten →